TrialAnnals of the rheumatic diseases2015

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial.

Gerd-Rűdiger Burmester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.